Skip to main content

Volume 29 - Issue 10 - October 2021

Peripheral Arterial Disease
10/10/2021
Jason R. Chapman, MD
I have noticed with my current endovascular approach that I am performing fewer secondary interventions, with more time between the interventions as well.
I have noticed with my current endovascular approach that I am performing fewer secondary interventions, with more time between the interventions as well.
I have noticed with my current...
10/10/2021
Cath Lab Digest
Lower-Extremity Intervention
10/09/2021
John A. Phillips, MD, FACC, FSCAI, RPVI
We now have the technology to get through the lesion, treat it with effective devices, and be more efficient. We can also bear that fiduciary responsibility with greater ease, because the 300mm Lutonix™ (BD) allows us to use a single balloon...
We now have the technology to get through the lesion, treat it with effective devices, and be more efficient. We can also bear that fiduciary responsibility with greater ease, because the 300mm Lutonix™ (BD) allows us to use a single balloon...
We now have the technology to...
10/09/2021
Cath Lab Digest
Outpatient Labs
10/08/2021
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP; Ryan Hebert, MHA, RT(R)
Once I have worked on a patient in an OBL, I have to talk them into a hospital procedure when it is necessary, because the OBL/ASC is so much more of a comfortable and non-rushed experience, and a better experience overall for patients and...
Once I have worked on a patient in an OBL, I have to talk them into a hospital procedure when it is necessary, because the OBL/ASC is so much more of a comfortable and non-rushed experience, and a better experience overall for patients and...
Once I have worked on a patient...
10/08/2021
Cath Lab Digest
RADIATION REDUCTION
10/08/2021
Dennis McDill
CLD talks with Dennis McDill, Director of Cardiovascular Services.
CLD talks with Dennis McDill, Director of Cardiovascular Services.
CLD talks with Dennis McDill,...
10/08/2021
Cath Lab Digest
Recently Published
10/08/2021
Subramaniam C. Krishnan, MD, FHRS
Atrial fibrillation (AF) patients account for a sixth of all strokes and blood clots originate from the left atrial appendage in the vast majority.
Atrial fibrillation (AF) patients account for a sixth of all strokes and blood clots originate from the left atrial appendage in the vast majority.
Atrial fibrillation (AF)...
10/08/2021
Cath Lab Digest
Your Path to Program Success: Expert Advice
10/08/2021
Kristin Truesdell
Healthcare is an ever-changing entity, so it is no wonder hospitals encounter difficulty in keeping current with reimbursement updates, especially amid a pandemic that’s swiftly approaching a two-year duration.
Healthcare is an ever-changing entity, so it is no wonder hospitals encounter difficulty in keeping current with reimbursement updates, especially amid a pandemic that’s swiftly approaching a two-year duration.
Healthcare is an ever-changing...
10/08/2021
Cath Lab Digest
SCAI Updates
10/06/2021
Each year, the American Medical Association (AMA) publishes a new CPT® book, containing all the new, deleted, and/or revised codes. New or revised guidelines are created, as well as new parentheticals (instructions listed under the codes).
Each year, the American Medical Association (AMA) publishes a new CPT® book, containing all the new, deleted, and/or revised codes. New or revised guidelines are created, as well as new parentheticals (instructions listed under the codes).
Each year, the American Medical...
10/06/2021
Cath Lab Digest

Feature

Calcium Corner
10/10/2021
Andrew J.P. Klein, MD, FACC, FSCAI
In the coronary realm, IVL allows us to treat in settings where otherwise it might not be possible, because it is an extremely safe technology.
In the coronary realm, IVL allows us to treat in settings where otherwise it might not be possible, because it is an extremely safe technology.
In the coronary realm, IVL...
10/10/2021
Cath Lab Digest
Clinical Update
10/10/2021
Arnold H. Seto, MD, MPA, CCDS, FACC, FSCAI; Jordan G. Safirstein, MD, FACC, FSCAI
The STAT2 trial is a follow-up study that enrolled 443 patients and attempted a full deflation of the TR Band at 60 minutes for both arms of the study, which offered more of an apples-to-apples comparison than the pilot study.
The STAT2 trial is a follow-up study that enrolled 443 patients and attempted a full deflation of the TR Band at 60 minutes for both arms of the study, which offered more of an apples-to-apples comparison than the pilot study.
The STAT2 trial is a follow-up...
10/10/2021
Cath Lab Digest

Column

Clinical Editor's Corner
10/06/2021
George W. Vetrovec, MD; John S. Marshall; Arnold H. Seto, MD, MPA, CCDS, FACC, FSCAI; Thomas Bashore; John W. Hirshfeld, Jr.; Samuel M. Butman, MD; Prashant Kaul, MD, FACC, FSCAI; Ajay J. Kirtane, MD, SM; David E. Kandzari, MD; Morton J. Kern, MD, MSCAI, FACC, FAHA; David J. Cohen, MD, MPH, MSc; Adnan K. Chhatriwalla, MD
A middle-aged man underwent a routine cath for coronary artery disease that showed non-obstructive mild coronary narrowings.
A middle-aged man underwent a routine cath for coronary artery disease that showed non-obstructive mild coronary narrowings.
A middle-aged man underwent a...
10/06/2021
Cath Lab Digest